Tara Sigdel

Dr. Tara Sigdel is a research scientist at the University of California San Francisco specializing in biomarker discovery for organ transplantation and kidney diseases. Her work leverages advanced molecular assays to develop non-invasive diagnostic tools that improve patient assessment and treatment monitoring in transplant medicine.

Her educational background includes:

• B.Sc. in Biology/Chemistry from Tribhuvan University, Nepal (1987-1989)
• M.Sc. in Chemistry from Tribhuvan University, Nepal (1990-1992)
• Ph.D. in Biochemistry from Miami University and Stanford University (2000-2005)
• Postdoctoral Training in Biomarker Discovery at Stanford University (2005-2009)

Dr. Sigdel's research integrates proteomics, genomics, and immunology to identify disease-specific biomarkers for transplant rejection and kidney pathologies. She employs cutting-edge technologies including mass spectrometry, single-cell sequencing, and spatial transcriptomics to decode molecular mechanisms in conditions like diabetic kidney disease and cystinosis. Her work bridges fundamental science with clinical application, focusing on translating molecular discoveries into practical diagnostic tools that can be implemented in patient care settings.

Analysis of her 15 most recent publications (2021-2025) reveals a dominant focus on kidney transplantation biology, with increasing emphasis on multi-omics integration and spatial profiling. Her research trajectory shows progression from biomarker discovery toward clinical implementation, particularly in urinary proteomics for non-invasive monitoring. Collaborative work through initiatives like the Kidney Precision Medicine Project demonstrates her commitment to large-scale translational research.

Her notable scientific achievements include:

• Deans Fellowship (2007-2008) from Stanford University
• Two Pediatric Research Fund – CHRP Awards (2008, 2009-2010)
• Helena Anna Henzl Gabor Award for International Congress attendance (2009)
• Transplant and Tissue Engineering Center of Excellence grant for urinary biomarker development

Dr. Sigdel maintains active research funding supporting her biomarker development programs, with strong evidence of successful grant acquisition through her continuous high-impact publications. Her collaborative approach is evident in multi-institutional projects involving over 50 co-investigators across 15 institutions in recent work. While specific mentoring metrics aren't detailed, her role as corresponding/co-corresponding author on numerous publications indicates active supervision of trainees.

Though no specific lab name is provided, Dr. Sigdel leads a research team within UCSF's transplant research ecosystem, contributing significantly to the Kidney Precision Medicine Project consortium. Her international collaborations, including the Nepal Family Cohort study, demonstrate a global research network focused on advancing precision medicine applications in diverse clinical settings.